Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

151
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
151
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

380
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
380
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

136
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
136
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Barriers to Effective Communication II01:21

Barriers to Effective Communication II

3.6K
The barriers to effective communication also include cultural barriers, semantic barriers, gender barriers, and time constraints.
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
3.6K
Elements Crucial for Effective Psychotherapy01:25

Elements Crucial for Effective Psychotherapy

37
Research has highlighted several critical factors that influence the effectiveness of psychotherapy, such as the therapeutic alliance, the therapist, and the client.
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
37

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidimensional menopausal symptom burden in Singapore - MARIE work package 2a population analysis.

Climacteric : the journal of the International Menopause Society·2026
Same author

Menopause and musculoskeletal health in English primary care: study protocol.

BJGP open·2026
Same author

Conservative treatments for chronic non-specific low back pain: time course network meta-analysis.

BMJ medicine·2026
Same author

Physical and mental health impact of perimenopause, menopause and post menopause in a diverse global population (MARIE Project- Global Chapter WP 2a): cross-sectional quantitative data from a mixed-methods study.

EClinicalMedicine·2026
Same author

Redefining testosterone reference ranges for adult females.

Journal of endocrinological investigation·2026
Same author

Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model.

Health technology assessment (Winchester, England)·2026

Related Experiment Video

Updated: Jun 21, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K

Factors affecting shared decision-making concerning menopausal hormone therapy.

Kanyada Koysombat1,2, Annice Mukherjee3, Sandhi Nyunt1,2

  • 1Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK.

Annals of the New York Academy of Sciences
|July 17, 2024
PubMed
Summary
This summary is machine-generated.

Menopause hormone therapy (MHT) decisions involve complex factors for both women and healthcare providers. Understanding these influences improves shared decision-making and long-term satisfaction with menopause care.

Keywords:
hormone replacement therapymenopausal hormone therapymenopauseshared decision‐making

More Related Videos

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

859
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 21, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

859
Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
05:32

Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model

Published on: August 11, 2023

1.7K

Area of Science:

  • Women's Health
  • Endocrinology
  • Healthcare Decision-Making

Background:

  • Menopausal hormone therapy (MHT) is recommended for symptom management.
  • Personalized care and shared decision-making are crucial in menopause management.
  • Decision-making regarding menopause care is influenced by multiple factors for both patients and providers.

Purpose of the Study:

  • To review evidence on factors influencing decision-making for menopause-related care.
  • To explore challenges faced by healthcare providers in MHT risk-benefit communication.
  • To understand women's perspectives and influences on their menopause care choices.

Main Methods:

  • Narrative review of existing evidence.
  • Synthesis of factors impacting patient and provider decision-making.
  • Analysis of influences including media and personal characteristics.

Main Results:

  • Healthcare providers face challenges in providing individualized risk estimates due to data complexity and time constraints.
  • Women's decisions are shaped by sociocultural, educational, demographic, and personal factors, alongside benefit-risk profiles.
  • Media, social media, and celebrity influence perception and decision-making around menopause.

Conclusions:

  • Understanding decision-making factors can enhance shared decision-making and treatment adherence.
  • Improved understanding leads to greater satisfaction with menopause care decisions and processes.
  • Addressing these factors can optimize resource use and long-term patient satisfaction.